A process for inhibiting complement activation via the alternative pathway

Details for Australian Patent Application No. 2003203746 (hide)

Owner Gliatech, Inc.

Inventors Parent, James B.; Brunden, Kurt R.; Gupta-Bansal, Rekha

Agent Baldwin Shelston Waters

Pub. Number AU-A-2003203746

Parent 92033

Filing date 16 April 2003

Wipo publication date 12 June 2003

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61M 001/36 Suction or pumping devices for medical purposes - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation

Event Publications

8 May 2003 Complete Application Filed

12 June 2003 Application Open to Public Inspection

  Published as AU-A-2003203746

4 November 2004 Assignment before Grant

  Gliatech Inc. The application has been assigned to Abgenix, Inc

29 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003203747-Improved seal with anti-theft device for articles having slender portions

2003203745-System and method for user modification of metadata in a shell browser